<VariationArchive RecordType="classified" VariationID="691295" VariationName="NM_001018113.1(FANCB):c.(?_-268)_(*160_?)del" VariationType="Deletion" Accession="VCV000691295" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-11" DateCreated="2019-09-29" MostRecentSubmission="2019-09-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="678981" VariationID="691295">
      <GeneList>
        <Gene Symbol="FANCB" FullName="FA complementation group B" GeneID="2187" HGNC_ID="HGNC:3583" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="14689524" stop="14873069" display_start="14689524" display_stop="14873069" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="14861528" stop="14891183" display_start="14861528" display_stop="14891183" Strand="-" />
          </Location>
          <OMIM>300515</OMIM>
          <Haploinsufficiency last_evaluated="2021-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FANCB">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FANCB">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001018113.1(FANCB):c.(?_-268)_(*160_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="14861529" stop="14891184" display_start="14861529" display_stop="14891184" variantLength="29656" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic, top-level">
          <NucleotideExpression>
            <Expression>NC_000023.11:g.14843408_14873063del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.14861529_14891184del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.14861529_14891184del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_496t1" sequenceAccession="LRG_496t1">
            <Expression>LRG_496t1:c.(?_-268)_(*160_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001018113.1(FANCB):c.(?_-268)_(*160_?)del AND Fanconi anemia complementation group B" Accession="RCV000851548" Version="1">
        <ClassifiedConditionList TraitSetID="3035">
          <ClassifiedCondition DB="MedGen" ID="C1845292">Fanconi anemia complementation group B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2015-08-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-08-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-09-29" MostRecentSubmission="2019-09-29">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25168418</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3035" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1275" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FANCONI PANCYTOPENIA, TYPE 2</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Fanconi anemia complementation group B</ElementValue>
                <XRef ID="MONDO:0010351" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FACB</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FA2</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">FANCB</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.</Attribute>
                <XRef ID="NBK1401" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FANCB-Related Fanconi Anemia</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301575</ID>
                <ID Source="BookShelf">NBK1401</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301753</ID>
                <ID Source="BookShelf">NBK5192</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2008">
                <URL>http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf</URL>
                <CitationText>Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008 (See 2020 Update)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2020">
                <URL>https://www.fanconi.org/images/uploads/other/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.pdf</URL>
                <CitationText>Fanconi Anemia Clinical Care Guidelines, Fifth Edition.</CitationText>
              </Citation>
              <XRef ID="84" DB="Orphanet" />
              <XRef ID="C1845292" DB="MedGen" />
              <XRef ID="MONDO:0010351" DB="MONDO" />
              <XRef Type="MIM" ID="300514" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1949380" SubmissionDate="2019-09-27" DateLastUpdated="2019-09-29" DateCreated="2019-09-29">
        <ClinVarSubmissionID localKey="FANCB_000028|OMIM:300514" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000994621" DateUpdated="2019-09-29" DateCreated="2019-09-29" Type="SCV" Version="1" SubmitterName="Leiden Open Variation Database" OrgID="506264" OrganizationCategory="other" OrgAbbreviation="LOVD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-08-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25168418</ID>
          </Citation>
          <Comment>Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FANCB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001018113.1:c.(?_-268)_(*160_?)del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.14861529_14891184del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300514" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5650909</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1949380" TraitType="Disease" MappingType="XRef" MappingValue="300514" MappingRef="OMIM">
        <MedGen CUI="C1845292" Name="Fanconi anemia complementation group B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

